CMP: 556

Sun Pharmaceutical Industries Limited manufactures and markets pharmaceuticals for domestic and international distribution. The Company's pharmaceutical portfolio includes drugs in the areas of diabetes, cardiology, neurology, psychiatry and gastroenterology.

Sun Pharmaceuticals is a safe large-cap buy in pharma space. Its currently trading at a P/E of 36 with decent dividend yields. It runs at a debt of 50 Crores, with cash in hand of 22 Crores. Revenues have fluctuated and settled down over the last 5 years. But, Profits have consistently grown from 461 Crores to 1383 Crores in the last 5 years on increasing margins. NPM has rocketed from 27% to 72% over the last 5 years. Buy and hold for long term gains.